Lost Money on Qiagen N.V. (QGEN)? Contact Levi & Korsinsky to Protect Your Rights

New York, New York--(Newsfile Corp. - May 11, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Qiagen N.V. (NYSE: QGEN) ("Qiagen N.V.")  concerning potential violations of the federal securities laws.

During the previous earnings call on February 5, 2026, CEO Thierry Bernard was confident: "You will see QuantiFERON picking up in Q2 accelerating to achieve between 6% and 7% growth" in 2026. He noted Qiagen's projections remained "perfectly aligned with the target that we gave during our Capital Market Day in June 2024."

On April 28, 2026, Qiagen walked back on these claims and CFO Roland Sackers revealed the disappointing guidance: sales were now projected to "continue at a largely unchanged level from the second quarter of 2025," and investors would have to wait for QuantiFERON to "return to a more normalized growth rate in 2027."

If you suffered a loss on your Qiagen N.V. securities and would like to explore a potential recovery under the federal securities laws, Learn More About the Investigation or contact Joseph E. Levi, Esq. via email at [e-mail] or call [phone] to speak to our team of experienced shareholder advocates.

WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[e-mail]
Tel: [phone]
Fax: [phone]

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/296863

The Qiagen Stock at the time of publication of the news with a raise of +0,20 % to 28,17EUR on Lang & Schwarz stock exchange (10. Mai 2026, 18:58 Uhr).

Schreibe Deinen Kommentar